Copyright Reports & Markets. All rights reserved.

Global Glaucoma Pharmaceutical Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Glaucoma Pharmaceutical Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Miosis Drugs
      • 1.4.3 Beta-blocker
      • 1.4.4 Adrenergic Agonists
      • 1.4.5 Carbonic Anhydrase Inhibitor
      • 1.4.6 Prostaglandin Derivative Agent
      • 1.4.7 Penetrates
    • 1.5 Market by Application
      • 1.5.1 Global Glaucoma Pharmaceutical Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Drugstore
      • 1.5.4 Online Sales
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Glaucoma Pharmaceutical Market Size
    • 2.2 Glaucoma Pharmaceutical Growth Trends by Regions
      • 2.2.1 Glaucoma Pharmaceutical Market Size by Regions (2014-2025)
      • 2.2.2 Glaucoma Pharmaceutical Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Glaucoma Pharmaceutical Market Size by Manufacturers
      • 3.1.1 Global Glaucoma Pharmaceutical Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Glaucoma Pharmaceutical Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Glaucoma Pharmaceutical Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glaucoma Pharmaceutical Key Players Head office and Area Served
    • 3.3 Key Players Glaucoma Pharmaceutical Product/Solution/Service
    • 3.4 Date of Enter into Glaucoma Pharmaceutical Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Glaucoma Pharmaceutical Market Size by Type (2014-2019)
    • 4.2 Global Glaucoma Pharmaceutical Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Glaucoma Pharmaceutical Market Size (2014-2019)
    • 5.2 Glaucoma Pharmaceutical Key Players in United States
    • 5.3 United States Glaucoma Pharmaceutical Market Size by Type
    • 5.4 United States Glaucoma Pharmaceutical Market Size by Application

    6 Europe

    • 6.1 Europe Glaucoma Pharmaceutical Market Size (2014-2019)
    • 6.2 Glaucoma Pharmaceutical Key Players in Europe
    • 6.3 Europe Glaucoma Pharmaceutical Market Size by Type
    • 6.4 Europe Glaucoma Pharmaceutical Market Size by Application

    7 China

    • 7.1 China Glaucoma Pharmaceutical Market Size (2014-2019)
    • 7.2 Glaucoma Pharmaceutical Key Players in China
    • 7.3 China Glaucoma Pharmaceutical Market Size by Type
    • 7.4 China Glaucoma Pharmaceutical Market Size by Application

    8 Japan

    • 8.1 Japan Glaucoma Pharmaceutical Market Size (2014-2019)
    • 8.2 Glaucoma Pharmaceutical Key Players in Japan
    • 8.3 Japan Glaucoma Pharmaceutical Market Size by Type
    • 8.4 Japan Glaucoma Pharmaceutical Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Glaucoma Pharmaceutical Market Size (2014-2019)
    • 9.2 Glaucoma Pharmaceutical Key Players in Southeast Asia
    • 9.3 Southeast Asia Glaucoma Pharmaceutical Market Size by Type
    • 9.4 Southeast Asia Glaucoma Pharmaceutical Market Size by Application

    10 India

    • 10.1 India Glaucoma Pharmaceutical Market Size (2014-2019)
    • 10.2 Glaucoma Pharmaceutical Key Players in India
    • 10.3 India Glaucoma Pharmaceutical Market Size by Type
    • 10.4 India Glaucoma Pharmaceutical Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Glaucoma Pharmaceutical Market Size (2014-2019)
    • 11.2 Glaucoma Pharmaceutical Key Players in Central & South America
    • 11.3 Central & South America Glaucoma Pharmaceutical Market Size by Type
    • 11.4 Central & South America Glaucoma Pharmaceutical Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Glaucoma Pharmaceutical Introduction
      • 12.1.4 Pfizer Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Merck
      • 12.2.1 Merck Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Glaucoma Pharmaceutical Introduction
      • 12.2.4 Merck Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.2.5 Merck Recent Development
    • 12.3 Allergan
      • 12.3.1 Allergan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Glaucoma Pharmaceutical Introduction
      • 12.3.4 Allergan Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.3.5 Allergan Recent Development
    • 12.4 Santen
      • 12.4.1 Santen Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Glaucoma Pharmaceutical Introduction
      • 12.4.4 Santen Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.4.5 Santen Recent Development
    • 12.5 Alcon
      • 12.5.1 Alcon Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Glaucoma Pharmaceutical Introduction
      • 12.5.4 Alcon Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.5.5 Alcon Recent Development
    • 12.6 Teva Pharmaceuticals
      • 12.6.1 Teva Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Glaucoma Pharmaceutical Introduction
      • 12.6.4 Teva Pharmaceuticals Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.6.5 Teva Pharmaceuticals Recent Development
    • 12.7 Fera Pharmaceuticals
      • 12.7.1 Fera Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Glaucoma Pharmaceutical Introduction
      • 12.7.4 Fera Pharmaceuticals Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.7.5 Fera Pharmaceuticals Recent Development
    • 12.8 Bausch & Lomb, Inc.
      • 12.8.1 Bausch & Lomb, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Glaucoma Pharmaceutical Introduction
      • 12.8.4 Bausch & Lomb, Inc. Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.8.5 Bausch & Lomb, Inc. Recent Development
    • 12.9 Akorn, Inc.
      • 12.9.1 Akorn, Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Glaucoma Pharmaceutical Introduction
      • 12.9.4 Akorn, Inc. Revenue in Glaucoma Pharmaceutical Business (2014-2019)
      • 12.9.5 Akorn, Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Glaucoma Pharmaceutical market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Glaucoma Pharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glaucoma Pharmaceutical development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Merck
      Allergan
      Santen
      Alcon
      Teva Pharmaceuticals
      Fera Pharmaceuticals
      Bausch & Lomb, Inc.
      Akorn, Inc.

      Market segment by Type, the product can be split into
      Miosis Drugs
      Beta-blocker
      Adrenergic Agonists
      Carbonic Anhydrase Inhibitor
      Prostaglandin Derivative Agent
      Penetrates

      Market segment by Application, split into
      Hospital Pharmacy
      Drugstore
      Online Sales

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Glaucoma Pharmaceutical status, future forecast, growth opportunity, key market and key players.
      To present the Glaucoma Pharmaceutical development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Glaucoma Pharmaceutical are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now